ATYR PHARMA, INC. (ATYR) valuation

Share price $0.78 · As of last filing 2026-03-31

Price-to-Earnings

P/E · Trailing Diluted

-1.07×

P/E history →

Price-to-Free-Cash-Flow

P/FCF · Trailing

-1.28×

P/FCF history →

Free-Cash-Flow Yield

FCF Yield · Trailing

-78.25%

FCF Yield history →

Enterprise-Value-to-EBITDA

EV/EBITDA · Trailing

-0.30×

EV/EBITDA history →

Underlying EBIT Margin

EBIT + SBC · Trailing

-35875.79%

Methodology →

Price-to-Sales

P/S · Trailing

402.53×

P/S history →

Price-to-Book

P/B · Latest filing

1.32×

P/B history →

Special situation detected — historical normalisation may not reflect go-forward economics. EPV and Reverse-DCF outputs below are anchored on history that no longer represents the entity going forward (net cash > 50% of market cap) . Inspect the balance sheet, recent 8-K filings, and the cards above before relying on these models.

net cash > 50% of market cap. Net cash $54.8M (cash $66.5M − debt $11.7M) = 71.7% of market cap $76.5M

Related tickers

DAN

Dana Incorporated

MRTN

MARTEN TRANSPORT, LTD.

UPST

Upstart Holdings, Inc.